Global Decentralised Clinical Trials Market 2026-2036: CAGR 11.5%

Visiongain’s latest report, Decentralised Clinical Trials Market Report 2026-2036, provides detailed forecasts and strategic analysis across study design, indication, technology, and end-user segments, including technology trends, trade and supply chain dynamics, and competitive positioning.

The global decentralised clinical trials market is projected to grow from US$11.3 billion in 2026 to US$33.5 billion by 2036, at a CAGR of 11.5% during the forecast period. The market is expected to add over US$8.7 billion in value, driven by digital health integration, expansion of hybrid trial models, and increased use of remote monitoring technologies.

Key Market Insights

The global decentralised clinical trials market will reach US$33.5 billion by 2036, growing at a CAGR of 11.5%
Growth is driven by digital health platforms, hybrid trial adoption, and real-time patient data capture
Key regions: North America, Europe, Asia Pacific
Leading companies: Medable, IQVIA, Parexel, Veeva Systems
Key trend: Integration of AI-enabled remote monitoring and data platforms

Download Free Sample Report (incl. forecasts, market data, and methodology)

Market Drivers

Patient-Centric and Hybrid Trial Models Driving Adoption

Hybrid trial models are replacing fully site-based approaches by combining in-person visits with remote monitoring, teleconsultations, and home-based care. This reduces patient burden, improves recruitment rates, and shortens trial timelines. Pharmaceutical companies and CROs are scaling these models across oncology, immunology, and vaccine studies to improve efficiency and retention.

Digital Health and Remote Monitoring Expansion

Wearables, mobile health platforms, and telemedicine are enabling continuous real-time data capture outside clinical sites. This improves data quality, supports broader patient participation, and allows faster decision-making during trials. Integration with cloud platforms standardises data collection and reduces operational complexity.

Technology & Innovation

AI-Driven Clinical Trial Platforms

Decentralised trial platforms are evolving into integrated digital ecosystems combining wearables, connected devices, and AI-driven analytics. These systems support predictive monitoring, adaptive trial design, and automated data processing, improving trial accuracy and scalability.

Trade & Supply Chain Dynamics

Global trade dynamics are directly increasing the cost base of decentralised clinical trials through tariffs on electronics, sensors, and medical components used in wearable devices and remote monitoring systems.

The market relies on globally sourced devices such as ECG patches, glucose monitors, and activity trackers, many of which are manufactured in Asia-Pacific and imported into the U.S. and Europe. U.S. tariffs introduced in 2024 on Chinese-origin electronics have increased landed costs for these components.

At the same time, multi-region trials face higher logistics costs and longer lead times for device deployment, particularly where large patient populations require standardised equipment.

Commercial Impact

Cost pressure: Sponsors and CROs are paying higher per-patient costs due to increased device pricing
Supply chain shifts: Procurement is moving towards diversified sourcing beyond China to reduce tariff exposure
Margin implications: Technology providers are raising prices to protect margins, increasing overall trial budgets
Competitive positioning: Providers with vertically integrated or regionalised supply chains are securing cost and delivery advantages

Market Opportunities

Faster Drug Development Through Digital Trials

Decentralised models enable faster study initiation, improved recruitment, and continuous data collection, reducing delays and accelerating time-to-market for new therapies. This supports more efficient clinical development pipelines and increases return on R&D investment.

Scaling Global Clinical Trial Access

Remote and hybrid trial models allow sponsors to reach broader and more diverse patient populations, improving enrolment and enabling trials in previously underserved regions. This expands commercial opportunities for both sponsors and service providers.

Competitive Landscape

The major players operating in the decentralised clinical trials market include Medable, IQVIA, Parexel, ICON plc, Veeva Systems, Labcorp Drug Development, and Thermo Fisher Scientific.

These companies are focusing on platform development, partnerships, and integration of digital health capabilities to strengthen their positions across global clinical trial delivery.

Recent Developments

December 2025 – Clinical Ink partnered with Tandem Diabetes Care to integrate automated insulin delivery data into connected device platforms, enabling real-time clinical data capture
October 2025 – Syneos Health partnered with CareMetx to improve patient access and reduce time to therapy through integrated support services
September 2025 – IQVIA launched a clinical trial financial management platform to improve cost tracking and operational efficiency

Frequently Asked Questions

What is driving growth in the decentralised clinical trials market?
Growth is driven by digital health adoption, hybrid trial models, and demand for faster, more efficient clinical development.
How are trade and supply chain dynamics affecting the market?
Tariffs and global sourcing dependencies are increasing device costs and raising overall trial budgets.
Who are the leading companies in the market?
Key players include Medable, IQVIA, Parexel, ICON plc, and Veeva Systems.

Download Free Sample Report (incl. forecasts, market data, and methodology)

About Visiongain

Established in 1998, Visiongain is an independent publisher of analyst-led market intelligence, delivering data-driven research, forecasts, and strategic insight across global industries and emerging markets. Visiongain supports evidence-based decision-making for investment, procurement, and long-term strategic planning.

Media Contact

press@visiongain.com
+44 (0)20 7336 6100
www.visiongain.com

Industry Market Reports

Message us today